ACCESSWIRE
18 Mar 2023, 00:05 GMT+10
dIFine 30 system is ZEUS Scientific's complete solution for IFA slide processing and digital immunofluorescence imaging
BRANCHBURG, NJ / ACCESSWIRE / March 17, 2023 / Today, ZEUS Scientific launched the dIFine 30 System, a powerful partnership pairing the ZEUS dIFine® digital immunofluorescence system with the new ZEUS SP30 slide processor. The SP30 is an easy-to-use and efficient walk-away benchtop instrument for IFA slide processing, designed to improve laboratory workflow and ensure high-quality results, including cover slipping. The SP30 can process up to 240 samples on 30 ZEUS IFA slides. With its three-probe system for fast, accurate pipetting and slide well washing, it precisely dispenses mounting media and adds coverslips, decreasing slide handling and the risk of artifacts/bubbles. The multi-drop individual well-to-well washing eliminates the risk of carryover or cross-contamination. ZEUS ANA IFA test kits feature ready-to-use reagents that can be directly loaded onto the SP30 - no pour off. Its user-friendly, intuitive software works with ZEUS dIFine, allowing for parallel processing and scanning sessions. The system connects to laboratories' LIS to receive test requests and share the worklist with dIFine, boosting efficiency.
The FDA-cleared ZEUS dIFine System is the next generation in IFA imaging, interpretation, and pattern recognition, designed to acquire, analyze, display and store digital images of ZEUS IFA HEp-2 cells. An automated digital scanner with intelligent software, dIFine quickly delivers positive/negative results and is FDA-cleared to suggest eight common ANA HEp-2 patterns (homogenous, speckled, centromere, nucleolar, nuclear dots, nuclear membrane, cytoplasmic (ribosomal and mitochondrial)).* dIFine also instantly locates and identifies mitotic cells, assisting in pattern identification. The ability to quickly view/validate all negative samples saves users valuable time. The built-in pattern atlas can be used as a reference or training tool, allowing side-by-side comparison with ZEUS proprietary images aligned with ICAP nomenclature.
ANA HEp-2 IFA is the American College of Rheumatology (ACR) gold standard for ANA testing. A pioneer in IFA technology, ZEUS has continually delivered quality products and expertise in autoimmune serology that laboratories have relied upon since 1976.
For 45+ years, laboratories have trusted ZEUS Scientific to provide high-quality IFA ANA HEp-2 products. The ZEUS proprietary cell fixation process allows technologists to work with cells containing natural, unaltered antigens and provides clear, crisp images; excellent cell morphology; and a high number of mitotic cells, all which make pattern determination easier.
With this new launch, laboratories can take their ANA IFA testing to the next level by pairing ZEUS's top-tier IFA ANA HEp-2 slides with the ZEUS dIFine 30 System. In addition, ZEUS is in the final phases of FDA submission for dIFine automated negative/positive determination and detection of anti-dsDNA (nDNA/Crithidia) antibodies in 2023.
For more information, please visit the ZEUS website or contact the ZEUS sales team.
* FDA 510(k) cleared. All suggested results obtained with ZEUS dIFine must be confirmed by a trained operator.
Contact Information
Travis Smyre
Vice President Commercial
[email protected]
908-243-4911
SOURCE: ZEUS Scientific
Get a daily dose of Raleigh Times news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Raleigh Times.
More InformationBENTON, Arkansas: Reuters reported that due to a reduction or elimination in evening and weekend shifts, Walmart will lay off ...
MOSCOW, Russia: As western automakers have left Russia since the start of the Ukraine war, the Chinese have rushed in ...
LONDON, England: Reuters has reported that struggling Virgin Orbit, owned by billionaire Richard Branson, is nearing a $200-million investment deal ...
NEW YORK CITY, New York: To comply with the requirements of the "Made in America" laws, a $7.5 billion federal ...
LONDON, England: During a Bloomberg conference held in London this week, Luke Ellis, CEO of hedge fund Man Group, said ...
NEW YORK, New York - Wall Street jumped on Friday, although gains were modest after bank shares in Europe came ...
Beijing [China], March 26 (ANI): If you reside close to a busy road, you may feel as though the constant ...
Eric Montross, a former national champion with North Carolina and first-round NBA draft pick, has been diagnosed with cancer, the ...
Amsterdam [Netherlands], March 25 (ANI): Reducing the amount of sugar added to sodas and the size of the packages offered ...
Emmanuel Rodriguez hit a three-run homer in the top of the ninth inning as the Minnesota Twins scored five runs ...
The Carolina Hurricanes are heading back to the postseason, but there still is work to be done. Despite losing four ...
Beijing [China], March 24 (ANI): If you live near a busy road you might feel like the constant sound of ...